JAK2 and Familial prostate cancer: The DU145 prostate cancer cell line expresses an autocrine IL-6 signaling loop [41] and was recently reported to be sensitive to the effects of a novel small molecule JAK2 inhibitor in vitro and in vivo[3], [41].